DSR - DRUG SAVINGS REPORT Trademark

Trademark Overview

On Tuesday, August 17, 2021, a trademark application was filed for DSR - DRUG SAVINGS REPORT with the United States Patent and Trademark Office. The USPTO has given the DSR - DRUG SAVINGS REPORT trademark a serial number of 90887632. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 2, 2024. This trademark is owned by Gemini Health LLC. The DSR - DRUG SAVINGS REPORT trademark is filed in the Advertising, Business and Retail Services category with the following description:

Medical cost management; Pharmaceutical cost management services and drug utilization review services
dsr - drug savings report

General Information

Serial Number90887632
Word MarkDSR - DRUG SAVINGS REPORT
Filing DateTuesday, August 17, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 6, 2022

Trademark Statements

Pseudo MarkDRUG SAVINGS REPORT DRUG SAVINGS REPORT
Goods and ServicesMedical cost management; Pharmaceutical cost management services and drug utilization review services
NOT AVAILABLE"DRUG SAVINGS REPORT"

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, October 6, 2021
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGemini Health LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSausalito, CA 94965
Party NameGemini Health LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSausalito, CA 94965

Trademark Events

Event DateEvent Description
Friday, August 20, 2021NEW APPLICATION ENTERED
Wednesday, October 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 18, 2022ASSIGNED TO EXAMINER
Friday, June 10, 2022NON-FINAL ACTION WRITTEN
Friday, June 10, 2022NON-FINAL ACTION E-MAILED
Friday, June 10, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 15, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 15, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 15, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 2, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 2, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 2, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, November 2, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 2, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, November 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 28, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, November 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 28, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 6, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, November 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 6, 2022PUBLISHED FOR OPPOSITION
Tuesday, July 25, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, January 31, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 6, 2023ASSIGNED TO EXAMINER
Tuesday, July 25, 2023SOU EXTENSION 1 FILED
Tuesday, July 25, 2023SOU EXTENSION 1 GRANTED
Thursday, July 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 29, 2024SOU TEAS EXTENSION RECEIVED
Monday, January 29, 2024SOU EXTENSION 2 FILED
Monday, January 29, 2024SOU EXTENSION 2 GRANTED
Wednesday, January 31, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 2, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, September 2, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

report savings drug services management cost review utilization pharmaceutical medical